RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of CHRS
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Evaluation of Coherus BioSciences stock downgraded after the last trading session.
(Updated on Mar 28, 2024)

Sell candidate since Mar 22, 2024 Gain 2.58% PDF

The Coherus BioSciences stock price fell by -1.24% on the last day (Thursday, 28th Mar 2024) from $2.42 to $2.39. During the last trading day the stock fluctuated 6.36% from a day low at $2.36 to a day high of $2.51. The price has risen in 6 of the last 10 days and is up by 10.14% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -470 thousand shares and in total, 2 million shares were bought and sold for approximately $5.00 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -15.97% during the next 3 months and, with a 90% probability hold a price between $1.44 and $2.20 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

CHRS Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Coherus BioSciences stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $2.42. On a fall, the stock will find some support from the short-term average at $2.39. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Thursday, February 15, 2024, and so far it has fallen -16.14%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Coherus BioSciences stock

Coherus BioSciences finds support from accumulated volume at $2.32 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.150 between high and low, or 6.36%. For the last week, the stock has had daily average volatility of 6.30%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CHRS) For The Upcoming Trading Day Of Monday 1st

For the upcoming trading day on Monday, 1st we expect Coherus BioSciences to open at $2.42, and during the day (based on 14 day Average True Range), to move between $2.20 and $2.58, which gives a possible trading interval of +/-$0.191 (+/-8.01%) up or down from last closing price. If Coherus BioSciences takes out the full calculated possible swing range there will be an estimated 16.02% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $2.32 (2.93%) than the resistance at $2.58 (7.95%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Coherus BioSciences stock A Buy?

Coherus BioSciences holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

Current score: -5.330 Strong Sell Candidate Downgraded

Predicted Opening Price for Coherus BioSciences of Monday, April 1, 2024

Fair opening price April 1, 2024 Current price
$2.42 ( 1.26%) $2.39

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for CHRS

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.57 7.53 %
R2 2.51 5.13 %
R1 2.48 3.65 %
Current price: 2.39
Support S1 2.36 -1.14 %
S2 2.33 -2.62 %
S3 2.27 -5.02 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 2.86 19.67 %
R2 2.62 9.62 %
R1 2.58 7.95 %
Current price 2.39
Support S1 2.32 -2.93%
S2 2.31 -3.35%
S3 2.30 -3.77%

FAQ

What is the symbol for Coherus BioSciences Stock and on which exchange is it traded?
The symbol for Coherus BioSciences is CHRS and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Coherus BioSciences Stock?
Coherus BioSciences holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

How to buy Coherus BioSciences Stock?
Coherus BioSciences Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Coherus BioSciences Stock.

What's the current price of Coherus BioSciences Stock?
As of the end of day on the 2024-03-28, the price of an Coherus BioSciences (CHRS) share was $2.39.

What is the 52-week high and low for Coherus BioSciences Stock?
The 52-week high for Coherus BioSciences Stock is $8.65 and the 52-week low is $1.44.

What is the market capitalization of Coherus BioSciences Stock?
As of the 2024-03-28, the market capitalization of Coherus BioSciences is 266.16M.

When is the next earnings date for Coherus BioSciences?
The upcoming earnings date for Coherus BioSciences is May 13, 2024.
Click to get the best stock tips daily for free!

About Coherus BioSciences

Coherus BioSciences Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. The company also develops Toripalimab, a novel anti-PD-1 antibody for second-line treatment of melanoma ... CHRS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT